Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | +3.85% |
|
-0.41% | -43.41% |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lewis Bender
CEO | Chief Executive Officer | 65 | 31/12/11 |
Joseph Talamo
DFI | Director of Finance/CFO | 55 | 12-10 |
John Wesolowski
AUD | Comptroller/Controller/Auditor | 65 | 28/02/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Goldberg
BRD | Director/Board Member | 64 | 30/04/18 |
Lewis Bender
CEO | Chief Executive Officer | 65 | 31/12/11 |
Emer Leahy
BRD | Director/Board Member | 58 | 31/05/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,711,877 | 7,216,976 ( 52.63 %) | 0 | 52.63 % |
Company contact information
Intensity Therapeutics, Inc.
1 Enterprise Drive Suite 430
06880, Shelton
+
http://www.intensitytherapeutics.com![address Intensity Therapeutics, Inc.(INTS)](https://cdn.zonebourse.com/static/address/130628057.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.41% | 66.5M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+35.11% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- INTS Stock
- Company Intensity Therapeutics, Inc.